Peer Review History
| Original SubmissionApril 29, 2025 |
|---|
|
Dear Dr. Hernandez Lucas, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Kindly revise the manuscript by addressing the comments provided by me and the reviewers.plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Priyanka Sharma Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. Thank you for stating the following financial disclosure: -->-->UNAM-->-->DGAPA/UNAM (IN203621-IN202224)-->-->CONAHCYT (CF-2023-I-2079) -->--> -->-->Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." -->-->If this statement is not correct you must amend it as needed. -->-->Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.-->--> -->-->3. Thank you for stating the following in the Acknowledgments Section of your manuscript: -->-->We would like to thank M. Dunn for stimulating discussions and critical reading. M. Fernández-Mora, F. J. Santana and A. Vazquez for scientific suggestions. This work was supported by grants from: Dirección General de Asuntos del Personal Académico, DGAPA/UNAM (IN203621-IN202224) and CONAHCYT (CF-2023-I-2079) to I.H.L.-->--> -->-->We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. -->-->Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: -->-->UNAM-->-->DGAPA/UNAM (IN203621-IN202224)-->-->CONAHCYT (CF-2023-I-2079) -->--> -->-->Please include your amended statements within your cover letter; we will change the online submission form on your behalf.-->--> -->-->4. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files.-->--> -->-->Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).-->--> -->-->For example, authors should submit the following data:-->--> -->-->- The values behind the means, standard deviations and other measures reported;-->-->- The values used to build graphs;-->-->- The points extracted from images for analysis.-->--> -->-->Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.-->--> -->-->If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories.-->--> -->-->If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.-->--> -->-->5. We note that you have included the phrase “data not shown” in your manuscript. Unfortunately, this does not meet our data sharing requirements. PLOS does not permit references to inaccessible data. We require that authors provide all relevant data within the paper, Supporting Information files, or in an acceptable, public repository. Please add a citation to support this phrase or upload the data that corresponds with these findings to a stable repository (such as Figshare or Dryad) and provide and URLs, DOIs, or accession numbers that may be used to access these data. Or, if the data are not a core part of the research being presented in your study, we ask that you remove the phrase that refers to these data.-->?> 6. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Authors, You have addressed an important organism causing a major public health problem. I appreciate the workflow of study. I have few comments provided below. Please submit a revised version including the comments from editor and reviewers. 1. You have stated , "A phyloT phylogenetic tree of species based on ribosomal proteins was obtained from the NCBI genome taxonomy database (GTDb).". Please provide the proper link or reference for the readers. 2. You found no difference between the LTTRs in S. Typhi and other less virulent serotypes. How will you explain the significance of LTTRs now? Please provide more extensive discussion. 3. The quality of images needs to be improved. Please save the files with higher resolution. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes Reviewer #3: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** Reviewer #1: 1) The Materials and Methods section briefly states that LTTRs were obtained from the Salmonella CT18 genome. However, the manuscript does not clarify the methodology used for their identification. The authors should elaborate on the approach: What specific tools, databases, or bioinformatic pipelines were used? Overall, the Methods section can be more descriptive. 2) Figure 1 needs improved visualization. The authors may consider redesigning this figure to enhance readability, perhaps by using a color-coded heatmap or a presence/absence matrix with clear gridlines. This would help the audience better interpret and appreciate the comparative distribution of LTTRs across strains or species. 3) I think a graphical presentation of the LTTR distribution will help the manuscript. The text refers multiple times to the common versus exclusive presence of LTTRs among strains. This information would be more impactful if presented graphically. The authors could consider including pie charts, bar plots, or Venn diagrams to summarize the shared and unique LTTRs across the dataset. 4) The claim regarding CysB as an evolutionary marker appears somewhat overstated. Unlike ribosomal proteins, which are universally conserved and widely used in phylogenetic studies, CysB is not present across all bacterial taxa and seems to be largely restricted to Enterobacteriaceae. At best, CysB may serve as a functional evolutionary marker within specific niches or lineages. 5) Moreover, regulatory genes such as CysB are often subject to horizontal gene transfer, which can confound phylogenetic interpretations. What are authors view on this. Maybe the authors should address these caveats and clarify whether their use of "evolutionary marker" refers to functional divergence rather than strict lineage tracing. Reviewer #2: This is a very interesting study in LysR-Type transcriptional regulators (LTTRs). Further research is needed, for better understanding the role of these proteins, in order to prevent and control infections caused by Salmonella, in adults and children. Reviewer #3: Dear Authors, Thank you for submitting your manuscript to PLoS ONE. Your study presents an insightful and methodologically strong investigation into the evolution and distribution of LTTRs in Salmonellae and other bacterial genera. The identification of core and accessory LTTR pools has meaningful implications for understanding bacterial adaptability and gene regulation. However, to improve the manuscript, kindly consider the following; • Please revise for grammatical accuracy and clarity, particularly in the abstract, introduction, and discussion. Some phrases are meaningless because of either too short or too long to understand. • Avoid repetition between results and discussion; use the latter to provide synthesis and implications. • Add clarifications to your methods, such as genome accession details and criteria for LTTR classification. • Where you discuss conserved LTTRs (e.g., CysB), explicitly indicate why it may serve as a genomic marker. • The name of bacterial spp. should be written in standard way of being italic, however, the same is missing in the text, this needs to be carefully revised. Once these revisions are made, the manuscript will be suitable for publication. Thank you again for your contribution. Best regards, Muhammad Athar Abbas, DVM, PhD ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Muhammad Athar Abbas, DVM, PhD ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Dear Dr. Hernandez Lucas, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript in Jan 01 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Priyanka Sharma Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: The authors present a study on the establishment of a Salmonella LTTR core, which is an interesting and potentially valuable contribution. The revised version shows substantial improvement compared with the previous submission, and several analyses appear promising. Before the manuscript can be considered for publication, however, a number of clarifications, linguistic improvements, and additional references are required to strengthen the scientific arguments and ensure clarity. The manuscript would also benefit from careful language editing, ideally with input from a native English speaker, as several sentences contain grammatical errors or unclear phrasing. Below are specific comments that should be addressed in the revised draft: Major and Minor Comments 1. Introduction Please provide a clear explanation of cysB and its biological role in the introduction. The introduction should also more thoroughly discuss the role and significance of LTTRs in Salmonella. The rationale for selecting cysB is not clearly articulated and should be stated explicitly. 2. Lines 29–30 This sentence appears incomplete. Please revise to clearly convey the intended meaning. 3. Lines 70–71 Please rewrite this sentence for clarity and correct grammar. 4. Lines 94–97 The filtering strategy used in the analysis needs to be described more clearly and in greater detail. 5. Lines 100–102 Please revise this statement. A phylogenetic tree is not typically used to assess the distribution of LTTRs. 6. Lines 104–105 Please check and correct the grammar. 7. Line 114 The phrase “CysB and ribosomal protein phylogenies” is unclear. The term phylogeny may not be the most appropriate here. Please revise for scientific accuracy. 8. Lines 115–118 The methods used for phylogenetic tree generation, including bootstrap values and all relevant parameters, should be described more thoroughly. 9. There are several existing studies reporting ribosomal phylogenetic trees. Please cite the relevant literature and discuss how your findings compare, particularly regarding clade structure and similarity. 10. Please discuss why LTTRs appear to be present in only specific serotypes and relate these observations to existing literature on LTTR expression, bacterial biology, and pathogenicity. 11. Since LTTR expression was identified in public databases, consider evaluating whether LTTR profiles correlate with antimicrobial susceptibility, if such metadata are available. 12. Lines 124–126 You mention that the primary reason for studying LTTRs is the high morbidity of Salmonella Typhi. Please clarify this rationale and specifically state why LTTRs were chosen for this investigation. 13. Lines 147–148 Please provide references supporting the statement that certain subspecies adapt to hosts or environments with a reduced number of LTTRs. 14. Lines 149–152 This statement seems overly general. Please provide scientific justification explaining why LTTR reduction might occur. 15. Lines 146–157 Please provide references and additional detail regarding the hypothetical proteins mentioned. Clarify whether the LTTR core differs among species or serotypes. 16. Lines 163–164 Are LTTR cores or cassettes present in other bacterial taxa? If so, please describe which genes are involved and how they compare to the Salmonella LTTR core, with appropriate references. Additionally, discuss whether the specific LTTR distribution might contribute to serotype-specific pathogenic behaviors. 17. Lines 185–186 Please clarify the meaning of “Salmonella taxonomic group.” 18. Lines 190–191 The heading “LTTRs of the Salmonella genus are present in Enterobacteriaceae Phyllobacteriaceae” is confusing, since Salmonella itself belongs to Enterobacteriaceae. Consider revising to something like “Presence of LTTRs in Other Enterobacteriaceae Members” to improve clarity. Lines 192–194: Please rewrite this section to convey the findings clearly. 19. Lines 202–203 Please clarify what is meant by “between 13 and 14.” 20. Line 206 Please revise the phrase “common evolutionary story of LTTR evolution” for clarity and scientific accuracy. 21. Lines 211–213 Please rewrite this statement for clarity and list the pathogens in a scientifically appropriate manner. 22. Lines 214–216 Please specify which bacteria share this particular order of LTTRs, and clarify whether this applies to all bacteria listed in lines 213–214. 23. Lines 218–221 The sentence contains repeated phrasing (“were obtained”). Please revise for clarity and grammatical correctness. 24. Lines 221–222 Please refer to the correct table number in the text. 25. Line 228 The term “Essential genome core” is not standard. Please use established terminology from phylogenomics. 26. Line 236 Please clarify how the presence of both variable and conserved regions is “fundamental for biological processes,” as stated. 27. Line 239 Please correct the grammar. 28. Lines 243–245 Are there references showing that any specific gene can serve as a phylogenetic classifier? In Salmonella, even MLST using seven housekeeping genes has limited discriminatory power. Please justify the claim that cysB can be used in this way, including supporting references or comparative examples. 29. Line 247 Please clarify the meaning of “Reconciliation” in this context. 30. Line 251 Please provide the species and accession numbers for sequences downloaded from each genus. 31. Please clarify the overall conclusion and practical relevance of your findings related to cysB. 32. The manuscript touches on transcriptional regulation by LTTRs but does not clearly explain its biological implications. Please expand on what LTTRs control and why this is relevant. 33. LTTRs are important for evolution and transcriptional regulation; however, this is not reflected in the discussion. Please elaborate and cite relevant literature. 34. Lines 275–278 The statement is unclear regarding whether LTTR number is dependent or independent of genome size. Please clarify and cite supporting references. 35. Line 298 When discussing genetic redundancy, please provide quantitative or descriptive information on how similar the LTTRs are. 36. Line 302 If LTTRs similar to Salmonella LTTRs are present in other species, please clarify this section to avoid implying that LTTRs are exclusive to Salmonella. Revise the wording to accurately describe how LTTRs are shared across species and how they differ. 37. Supplementary Table 1 Please clarify whether the listed numbers represent genome accession IDs. 38. Figures are currently low resolution and difficult to evaluate. Please provide high-quality, high-resolution figures in the revised submission. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: (No Response) Reviewer #2: This is a very interesting study in LysR-Type transcriptional regulators (LTTRs). Further research is needed, for better understanding the role of these proteins, in order to prevent and control infections caused by Salmonella, in adults and children. I have no further comments to add. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 2 |
|
Distribution and evolution of the LysR-Type transcriptional regulators of the Salmonella genus. PONE-D-25-23217R2 Dear Authors, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Priyanka Sharma Academic Editor PLOS One Additional Editor Comments (optional): Thank you for addressing all the comments. I am happy to accept this manuscript for publication. |
| Formally Accepted |
|
PONE-D-25-23217R2 PLOS One Dear Dr. I, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Priyanka Sharma Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .